2017 annual financial data
Biodexa Pharmaceuticals 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,309.71%.
Operating income was -11,776,000 USD and net income was -11,705,000 USD.
Operating cash flow was -12,953,000 USD.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 989,000 USD
- Operating income
- -11,776,000 USD
- Net income
- -11,705,000 USD
- Operating cash flow
- -12,953,000 USD